Leptomeningeal carcinomatosis: remarkable diagnosis with diffusion weighted MR imaging

References (10)

1. DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol. 1998;38:245–52
2. Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD. Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005;103:2355-62
3. Yokote A, Kawamoto T, Namioka T, Moteki Y, Kawamata T. Diagnosis of leptomeningeal metastasis without a history of malignancy in the absence of cerebrospinal fluid abnormalities. Clin Neurol Neurosurg. 2014;119:88-90
4. Guo JW, Zhang XT, Chen XS, Zhang XC, Zheng GJ, Zhang BP et al. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. World J Gastroenterol. 2014;20:2120-6
5. Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol. 1999;246:810-4
6. Pavlidis N. The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol. 2004;15:285-91
7. Yousem DM, Patrone PM, Grossman RI. Leptomeningealmetastases: MR evaluation. J Comput Assist Tomogr. 1990;14:255-61
8. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR. 2007;188:1622–35
9. Hu YF, Chang FC, Hu HH, Hsu LC. Novel diffusion-weighted magnetic resonance imaging findings in leptomeningeal carcinomatosis: a case report. Acta Radiol. 2006;47:1089-90
10. Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. Lancet Oncol. 2010;11:871-9.